On May 7, 2024 Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, reported that company management will participate in a fireside chat at two upcoming investor conferences (Press release, Syros Pharmaceuticals, MAY 7, 2024, View Source [SID1234642798]). Details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
JMP Securities 2024 Life Sciences Conference
Date: Tuesday, May 14
Presentation Time: 11:00 a.m. ET
Location: New York Hilton Midtown, 1335 Sixth Avenue, New York, NY
TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO (Free ASCO Whitepaper) & EHA (Free EHA Whitepaper)
Date: Wednesday, May 29
Presentation Time: 1:00 p.m. ET
Location: Virtual
To access the webcasts and subsequent archived recording of each event, please visit the Investors & Media section of the Syros website at www.syros.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.